Marta, a 49-year-old female, presents with a range of intrusive symptoms secondary to unmanaged Crohn's disease. These symptoms often interrupt Marta's work and sleep, causing anxiety.
In this case study, we explore how Marta’s team prescribed a combination of medical cannabis products to treat her symptoms and improve her quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of Crohn’s disease and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for common symptoms of Crohn’s disease
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of symptoms of Crohn’s disease
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Mario, a 40-year-old male presents with respiratory symptoms and sleep difficulties associated with his diagnosis of chronic obstructive pulmonary disease.After being hospitalised 3 times in recent months, despite following his current treatment plan, Mario is seeking a more effective solution.In this case study, we explore how Mario’s team prescribed non-inhaled medical cannabis products to treat his respiratory symptoms, restore his sleep quality, and improve his quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the pathophysiology of COPD and identify common management strategies
Discuss the potential benefits and limitations of medical cannabis as a treatment option for patients with COPD
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of COPD
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Rachel, a 40-year-old female, presents with migraines, insomnia and chronic abdominal pain secondary to a recent nephrectomy due to chronic kidney disease.After trying many medications with only minimal symptom relief, Rachel’s desperate to find an alternative solution.In this case study, we explore how Rachel’s team prescribed medical cannabis to help manage her pain and insomnia and improve her overall quality of life.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain how and why chronic renal kidney disease affects patients
Discuss the potential benefits and limitations of medical cannabis as a treatment option for chronic renal kidney disease, nephrectomy, migraines and nausea and vomiting
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of chronic renal disease, nephrectomy, migraines, nausea and vomiting
Devise treatment plans that consider patient safety and minimise risk
Offer effective patient education and treatment advice on the therapeutic use of medical cannabis
Jen, a 21 year old woman experiences a couple of seizures per week due to photosensitive epilepsy.
This case study explores how Jen's team helped her reduce the duration and the frequency of her seizures with medical cannabis.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Demonstrate an understanding of safe prescribing and risks associated with medical cannabis and Epilepsy
Assess the suitability of cannabis treatment in patients with Epilepsy
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management
Monitor and provide titration advice around cannabinoid medicines
Apply critical safety considerations in patient centred care
Navigate the regulatory frameworks surrounding medical cannabis provision in Australia
46 year old Robert is dealing with a lot of stress at work. This is affecting his quality of sleep.
Explore how Robert's team helped him combat situational stress and prescribed medical cannabis to improve his overall sleep quality.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management of patients with insomnia
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for insomnia
Apply critical safety considerations & provide patient education & treatment advice regarding MC treatment
Violet, a seventy-seven year old woman, is in palliative care and undergoing radiation therapy.
As she enters her end of life (EOL) period, she's looking to medical cannabis to improve her comfort and alleviate the pain caused by the side effects of the other therapies she's undergoing.
In this case study, we explore how Violet's team devised a suitable treatment plan that addressed her side effects and improved her quality of life (QOL) during her EOL period.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Define the palliative approach to care and outline key clinical assessments
Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management in palliative care
Identify suitable candidates for medical cannabis treatment
Apply critical safety considerations/risk mitigation strategies for patients using medical cannabis in palliative care
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in palliative care
Discuss product usage and critical safety considerations with patients in patient-centred care
Zoey, a 46 year old female is seeking treatment for her chemotherapy-related symptoms.
Zoey is currently undergoing chemotherapy as she was diagnosed with breast cancer at the start of 2023. There is risk of hepatic injury as medical cannabis and chemotherapy can both effect the liver.
This case study explores how Zoey's team managed the symptoms of her chronic pain, fatigue, low mood and lack of appetite using medical cannabis to to combat Zoey's chemotherapy symptoms and regain her sense of self.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Discuss the potential benefits and limitations of medical cannabis as a treatment option for symptomatic management of chemotherapy and breast cancer
Identify suitable candidates for medical cannabis treatment
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management of Breast cancer and chemotherapy
Apply critical safety considerations & provide patient education & treatment advice regarding MC treatment
Lee has experienced anxiety for much of her adult life, but her symptoms have recently intensified—interfering with work, sleep, and daily functioning. Having previously trialled SSRIs with limited success, she is now exploring medical cannabis as a potential treatment option.
This case study follows Lee’s clinical assessment and treatment planning process, highlighting the key factors considered by her healthcare team in determining suitability for medical cannabis. Practitioners will examine how THC and CBD interact with anxiety symptoms, how patient history informs treatment planning, and what safety precautions are critical in minimising adverse effects—particularly with THC.
The module also explores regulatory considerations under the TGA framework and provides practical guidance on how to approach patient education and shared decision-making when discussing medical cannabis for anxiety management.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Discuss the relationship between THC, CBD and anxiety
Discuss the TGA requirements, potential benefits and limitations of medical cannabis as a treatment option for anxiety
Identify patients with anxiety who are suitable candidates for medical cannabis treatment
Collect detailed patient information
Apply critical safety considerations and provide patient education and treatment advice regarding medical cannabis treatment for anxiety
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management for anxiety
“I’m not even 40 but I feel like I’m 80.”
Johanna presented with chronic neuropathic pain and spasticity in her hands and feet due to multiple sclerosis. It was impacting her mobility and sleep, the effects of which had flowed into her career and finances.
Living with her parents while awaiting NDIS support, medical cannabis seemed like a promising treatment option but posed a risk with her Natalizumab use, requiring sound management to avoid potential hepatic injury. Financial constraints added complexity to accessing medical cannabis.
Discover how Johanna's team crafted an affordable and effective medical cannabis treatment, addressing her pain, sleep issues, and restoring her sense of self.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Demonstrate an understanding of the pathophysiology of MS
Discuss common treatment options for MS
Discuss how cannabinoid-based therapies may be an effective treatment option for symptom management in patients with MS
Explain the TGA guidance for providing medical cannabis as a treatment for patients with MS
Collect detailed patient information
Apply critical safety considerations/risk mitigation strategies for patients presenting with potential for hepatic injury
Discuss product usage and critical safety considerations with patients in patient-centred care
Sixty-year-old Jen was hesitant when she walked into the consultation room. She had been experiencing severe ankle pain caused by chronic regional pain syndrome and her treatments to date hadn’t done the trick. But medical cannabis? Wouldn’t she end up walking around “like a zombie”?
To complicate matters further, Jen has a history of now-stable cardiovascular disease. THC and CBD can affect cardiac functioning and interact with common POAC drugs.
But, all hope was not lost! In this case study, find out how Jen’s team safely treated her pain and secondary insomnia using medical cannabis, and minimised psychotropic effects so she remained her lively, vital self throughout treatment.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain the cardiac effects of medical cannabis
Discuss the potential benefits and limitations of medical cannabis as a treatment option in patients with cardiac disease
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management
Apply critical safety considerations/risk mitigation strategies for patients presenting with cardiac concerns
Discuss potential drug-drug interactions
Provide medication safety education to patients around drug-drug interactions
Fourty-three year old Luna has been experiencing a lot of mental health ups and downs. But recently there have been more “downs” than “ups”. Despite taking pharmaceutical treatments, her anxiety and depression are out of control, and it’s affecting her sleep.
But Luna has a coconut and lavender allergy – both of which can be caused by compounds also found in medical cannabis. And, there is evidence to suggest that THC can exacerbate anxiety and in some cases cause paranoia.
In this case study, explore how Luna’s team safely prescribed medical cannabis so she was feeling better and sleeping soundly in no time.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain why coconut and lavender allergies, and anxiety, are risk factors for using medical cannabis
Identify ingredients in medical cannabis products that commonly cause allergic or hypersensitive reactions
Apply critical safety considerations/risk mitigation strategies for patients presenting with allergies and anxiety concerns
Facilitate discussions with patients around medical cannabis as a therapeutic option for symptom management
Provide medication safety education to patients
Fifty-six year old Stephen, an avid gardener, has hit a rough patch. He’s out of action because of the chronic pain in his back, and gout pain in his wrists and ankles. He’s considering medical cannabis as a therapeutic option.
The complication? He has hepatic fibrosis from fatty liver of moderate severity, resulting in reduced hepatic function.
In this case study, explore how his team safely prescribed medical cannabis to Stephen, helping him manage his pain and get back onto his feet – and into his garden.
Preview this module by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this module, you’ll be able to:
Explain how medical cannabis interacts with the body, including the mechanisms of action and metabolism
Apply critical safety considerations / risk mitigation strategies for patients presenting with hepatic dysfunction or impairment
Discuss the potential benefits and limitations of medical cannabis as a treatment option for patients with hepatic dysfunction
Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management
Educate patients (on their individual case) on how to safely apply their treatment with medical cannabis
